FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

37540911000001106: Lyrinel XL 5mg tablets (Mawdsley-Brooks & Company Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 04-Sep 2019. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
357361000001111 Lyrinel XL 5mg tablets (Mawdsley-Brooks & Company Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
357371000001118 Lyrinel XL 5mg tablets (Mawdsley-Brooks & Company Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Lyrinel XL 5mg tablets (Mawdsley-Brooks & Company Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Lyrinel XL 5mg tablets (Mawdsley-Brooks & Company Ltd) Has NHS dm+d (dictionary of medicines and devices) parallel import indicator Parallel Import - supplier (qualifier value) false Inferred relationship Existential restriction modifier
Lyrinel XL 5mg tablets (Mawdsley-Brooks & Company Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Lyrinel XL 5mg tablets (Mawdsley-Brooks & Company Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Lyrinel XL 5mg tablets (Mawdsley-Brooks & Company Ltd) Is a Oxybutynin 5mg modified-release tablets false Inferred relationship Existential restriction modifier
Lyrinel XL 5mg tablets (Mawdsley-Brooks & Company Ltd) Is a Lyrinel XL true Inferred relationship Existential restriction modifier
Lyrinel XL 5mg tablets (Mawdsley-Brooks & Company Ltd) Has specific active ingredient Oxybutynin hydrochloride true Inferred relationship Existential restriction modifier
Lyrinel XL 5mg tablets (Mawdsley-Brooks & Company Ltd) Has dispensed dose form Modified-release oral tablet true Inferred relationship Existential restriction modifier
Lyrinel XL 5mg tablets (Mawdsley-Brooks & Company Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Lyrinel XL 5mg tablets (Mawdsley-Brooks & Company Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Lyrinel XL 5mg tablets (Mawdsley-Brooks & Company Ltd) Has NHS dm+d (dictionary of medicines and devices) parallel import indicator Parallel import true Inferred relationship Existential restriction modifier
Lyrinel XL 5mg tablets (Mawdsley-Brooks & Company Ltd) Is a Oxybutynin hydrochloride 5mg m/r tablet false Inferred relationship Existential restriction modifier
Lyrinel XL 5mg tablets (Mawdsley-Brooks & Company Ltd) Is a Oxybutynin 5mg modified-release tablets true Inferred relationship Existential restriction modifier
Lyrinel XL 5mg tablets (Mawdsley-Brooks & Company Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Lyrinel XL 5mg tablets (Mawdsley-Brooks & Company Ltd) 30 tablet Has AMP True Lyrinel XL 5mg tablets (Mawdsley-Brooks & Company Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start